Supplement Improves Cognitive Benefits in Mouse Model of Alzheimer’s Disease

News   Feb 07, 2018 | By the National Institutes of Health (NIH)

 
Compound Prevents Neurological Damage, Shows Cognitive Benefits in Mouse model of Alzheimer’s Disease

The brains of mouse models treated with the supplement nicotinamide riboside showed reduced tau and less DNA damage than non-treated mice. (Similar to pictured). Credit: National Institutes of Health

 
 
 

RELATED ARTICLES

Mechanism Controlling Multiple Sclerosis Risk Identified

News

Researchers at Karolinska Institutet have now discovered a new mechanism of a major risk gene for multiple sclerosis (MS) that triggers disease through so-called epigenetic regulation. They also found a protective genetic variant that reduces the risk for MS through the same mechanism.

READ MORE

Scientists Discover Fundamental Rule of Brain Plasticity

News

When one synapse strengthens, neighboring synapses weaken immediately based on the action of a crucial protein called Arc.

READ MORE

The Case of the Missing Brain Region is Solved

News

Researchers demonstrate that subplate neurons survive, and in fact become part of the adult cerebral cortex.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Drug Discovery Neuroscience

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE
 

We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy